{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:52:00Z","timestamp":1777870320389,"version":"3.51.4"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-024-02012-8","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T09:01:39Z","timestamp":1720083699000},"page":"163-169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bone mineral density assessment in patients with cystinuria"],"prefix":"10.1093","volume":"38","author":[{"given":"Viola","family":"D\u2019Ambrosio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Capolongo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Caletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Vietri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Ambrogio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianmarco","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra F.","family":"Perna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Orefice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Gremese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Varriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Gatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Fassio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovambattista","family":"Capasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Gambaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1379-022X","authenticated-orcid":false,"given":"Pietro Manuel","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,7,4]]},"reference":[{"key":"2012_CR1","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s00467-021-05342-y","volume":"37","author":"V D\u2019Ambrosio","year":"2022","unstructured":"D\u2019Ambrosio V, Capolongo G, Goldfarb D et al (2022) Cystinuria: an update on pathophysiology, genetics, and clinical management. Pediatr Nephrol 37:1705\u20131711. https:\/\/doi.org\/10.1007\/s00467-021-05342-y","journal-title":"Pediatr Nephrol"},{"key":"2012_CR2","doi-asserted-by":"publisher","first-page":"842","DOI":"10.2215\/CJN.06680714","volume":"10","author":"C Prot-Bertoye","year":"2015","unstructured":"Prot-Bertoye C, Lebbah S, Daudon M et al (2015) CKD and its risk factors among patients with cystinuria. CJASN 10:842\u2013851. https:\/\/doi.org\/10.2215\/CJN.06680714","journal-title":"CJASN"},{"key":"2012_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.06.035","author":"A Servais","year":"2020","unstructured":"Servais A, Thomas K, Strologo LD et al (2020) Cystinuria: clinical practice recommendation. Kidney Int. https:\/\/doi.org\/10.1016\/j.kint.2020.06.035","journal-title":"Kidney Int"},{"key":"2012_CR4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00240-019-01110-8","volume":"47","author":"F Kum","year":"2019","unstructured":"Kum F, Wong K, Game D et al (2019) Hypertension and renal impairment in patients with cystinuria: findings from a specialist cystinuria centre. Urolithiasis 47:357\u2013363. https:\/\/doi.org\/10.1007\/s00240-019-01110-8","journal-title":"Urolithiasis"},{"key":"2012_CR5","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1038\/ki.2009.189","volume":"76","author":"SM Moe","year":"2009","unstructured":"Moe SM et al (2009) Introduction and definition of CKD\u2013MBD and the development of the guideline statements. Kidney Int 76:S3\u2013S8. https:\/\/doi.org\/10.1038\/ki.2009.189","journal-title":"Kidney Int"},{"key":"2012_CR6","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1093\/hmg\/ddg189","volume":"12","author":"T Peters","year":"2003","unstructured":"Peters T (2003) A mouse model for cystinuria type I. Hum Mol Genet 12:2109\u20132120. https:\/\/doi.org\/10.1093\/hmg\/ddg189","journal-title":"Hum Mol Genet"},{"key":"2012_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.33393\/jcb.2022.2328","volume":"11","author":"L Albanese","year":"2022","unstructured":"Albanese L, Caliendo G, D\u2019elia G et al (2022) Diagnostic utility of FGF-23 in mineral bone disorder during chronic kidney disease. J Circ Biomark 11:1\u20134. https:\/\/doi.org\/10.33393\/jcb.2022.2328","journal-title":"J Circ Biomark"},{"key":"2012_CR8","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s40620-016-0329-y","volume":"29","author":"G Gambaro","year":"2016","unstructured":"Gambaro G, Croppi E, Coe F et al (2016) Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol 29:715\u2013734. https:\/\/doi.org\/10.1007\/s40620-016-0329-y","journal-title":"J Nephrol"},{"key":"2012_CR9","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1001\/jama.284.8.972","volume":"284","author":"JM Chandler","year":"2000","unstructured":"Chandler JM, Zimmerman SI, Girman CJ et al (2000) Low bone mineral density and risk of fracture in white female nursing home residents. JAMA 284:972\u2013977. https:\/\/doi.org\/10.1001\/jama.284.8.972","journal-title":"JAMA"},{"key":"2012_CR10","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1046\/j.1523-1755.1998.00779.x","volume":"53","author":"LJ Melton","year":"1998","unstructured":"Melton LJ, Crowson CS, Khosla S et al (1998) Fracture risk among patients with urolithiasis: a population-based cohort study. Kidney Int 53:459\u2013464. https:\/\/doi.org\/10.1046\/j.1523-1755.1998.00779.x","journal-title":"Kidney Int"},{"key":"2012_CR11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ki.2010.473","volume":"79","author":"K Sakhaee","year":"2011","unstructured":"Sakhaee K, Maalouf NM, Kumar R et al (2011) Nephrolithiasis-associated bone disease: pathogenesis and treatment options. Kidney Int 79:393\u2013403. https:\/\/doi.org\/10.1038\/ki.2010.473","journal-title":"Kidney Int"},{"key":"2012_CR12","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1007\/s00198-016-3658-8","volume":"27","author":"P Lucato","year":"2016","unstructured":"Lucato P, Trevisan C, Stubbs B et al (2016) Nephrolithiasis, bone mineral density, osteoporosis, and fractures: a systematic review and comparative meta-analysis. Osteoporos Int 27:3155\u20133164. https:\/\/doi.org\/10.1007\/s00198-016-3658-8","journal-title":"Osteoporos Int"},{"key":"2012_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/BF03345376","volume":"28","author":"F Vescini","year":"2005","unstructured":"Vescini F, Buffa A, La Manna G et al (2005) Long-term potassium citrate therapy and bone mineral density in idiopathic calcium stone formers. J Endocrinol Invest 28:218\u2013222. https:\/\/doi.org\/10.1007\/BF03345376","journal-title":"J Endocrinol Invest"},{"key":"2012_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1210\/jc.2012-3099","volume":"98","author":"S Jehle","year":"2013","unstructured":"Jehle S, Hulter HN, Krapf R (2013) Effect of potassium citrate on bone density, microarchitecture, and fracture risk in healthy older adults without osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab 98:207\u2013217. https:\/\/doi.org\/10.1210\/jc.2012-3099","journal-title":"J Clin Endocrinol Metab"},{"key":"2012_CR15","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.2215\/CJN.10981114","volume":"10","author":"HL Rhodes","year":"2015","unstructured":"Rhodes HL, Yarram-Smith L, Rice SJ et al (2015) Clinical and genetic analysis of patients with cystinuria in the United Kingdom. Clin J Am Soc Nephrol 10:1235\u20131245. https:\/\/doi.org\/10.2215\/CJN.10981114","journal-title":"Clin J Am Soc Nephrol"},{"key":"2012_CR16","doi-asserted-by":"publisher","first-page":"842","DOI":"10.2215\/CJN.06680714","volume":"10","author":"C Prot-Bertoye","year":"2015","unstructured":"Prot-Bertoye C, Lebbah S, Daudon M et al (2015) CKD and its risk factors among patients with cystinuria. Clin J Am Soc Nephrol 10:842\u2013851. https:\/\/doi.org\/10.2215\/CJN.06680714","journal-title":"Clin J Am Soc Nephrol"},{"key":"2012_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/gut.2.4.323","volume":"2","author":"MD Milne","year":"1961","unstructured":"Milne MD, Asatoor AM, Edwards KDG, Loughridge LW (1961) The intestinal absorption defect in cystinuria. Gut 2:323\u2013337","journal-title":"Gut"},{"key":"2012_CR18","first-page":"285","volume":"23","author":"AM Asatoor","year":"1962","unstructured":"Asatoor AM, Lacey BW, London DR, Milne MD (1962) Amino acid metabolism in cystinuria. Clin Sci 23:285","journal-title":"Clin Sci"},{"key":"2012_CR19","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1172\/JCI105157","volume":"44","author":"SO Thier","year":"1965","unstructured":"Thier SO, Segal S, Fox M et al (1965) Cystinuria: defective intestinal transport of dibasic amino acids and cys tine. J Clin Invest 44:442\u2013448. https:\/\/doi.org\/10.1172\/JCI105157","journal-title":"J Clin Invest"},{"key":"2012_CR20","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1172\/JCI105028","volume":"43","author":"CF McCarthy","year":"1964","unstructured":"McCarthy CF, Borland JL Jr, Lynch HJ Jr, Owen EE, Tyor MP (1964) Defectiveuptakeof basic amino acids and L-cystine by intestinal mucosa of patients with cystinuria. J Clin Invest 43:1518","journal-title":"J Clin Invest"},{"key":"2012_CR21","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1136\/jcp.27.6.500","volume":"27","author":"AM Asatoor","year":"1974","unstructured":"Asatoor AM, Freedman PS, Gabriel JR et al (1974) Amino acid imbalance in cystinuria. J Clin Pathol 27:500\u2013504. https:\/\/doi.org\/10.1136\/jcp.27.6.500","journal-title":"J Clin Pathol"},{"key":"2012_CR22","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/S0021-9258(17)33859-0","volume":"251","author":"AJ Garber","year":"1976","unstructured":"Garber AJ, Karl IE, Kipnis DM (1976) Alanine and glutamine synthesis and release from skeletal muscle. I. Glycolysis and amino acid release. J Biol Chem 251:826\u2013835","journal-title":"J Biol Chem"},{"key":"2012_CR23","doi-asserted-by":"publisher","first-page":"e0250437","DOI":"10.1371\/journal.pone.0250437","volume":"16","author":"Z Teng","year":"2021","unstructured":"Teng Z, Zhu Y, Yu X et al (2021) An analysis and systematic review of sarcopenia increasing osteopenia risk. PLoS\u00a0ONE 16:e0250437. https:\/\/doi.org\/10.1371\/journal.pone.0250437","journal-title":"PLoS\u00a0ONE"},{"key":"2012_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1042\/bj0320113","volume":"32","author":"HA Krebs","year":"1938","unstructured":"Krebs HA, Salvin E, Johnson WA (1938) The formation of citric and alpha-ketoglutaric acids in the mammalian body. Biochem J 32:113\u2013117. https:\/\/doi.org\/10.1042\/bj0320113","journal-title":"Biochem J"},{"key":"2012_CR25","doi-asserted-by":"publisher","first-page":"22425","DOI":"10.1073\/pnas.1009219107","volume":"107","author":"Y-Y Hu","year":"2010","unstructured":"Hu Y-Y, Rawal A, Schmidt-Rohr K (2010) Strongly bound citrate stabilizes the apatite nanocrystals in bone. Proc Natl Acad Sci 107:22425\u201322429. https:\/\/doi.org\/10.1073\/pnas.1009219107","journal-title":"Proc Natl Acad Sci"},{"key":"2012_CR26","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s11255-018-2044-1","volume":"51","author":"L Kovacevic","year":"2019","unstructured":"Kovacevic L, Caruso JA, Lu H et al (2019) Urine proteomic profiling in patients with nephrolithiasis and cystinuria. Int Urol Nephrol 51:593\u2013599. https:\/\/doi.org\/10.1007\/s11255-018-2044-1","journal-title":"Int Urol Nephrol"},{"key":"2012_CR27","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/s0022-5347(17)41019-6","volume":"141","author":"K Sakhaee","year":"1989","unstructured":"Sakhaee K, Poindexter JR, Pak CY (1989) The spectrum of metabolic abnormalities in patients with cystine nephrolithiasis. J Urol 141:819\u2013821. https:\/\/doi.org\/10.1016\/s0022-5347(17)41019-6","journal-title":"J Urol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-02012-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-024-02012-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-02012-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:52:49Z","timestamp":1777564369000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/38\/1\/163\/8304247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,4]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["2012"],"URL":"https:\/\/doi.org\/10.1007\/s40620-024-02012-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.12.06.23299590","asserted-by":"object"}]},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,4]]},"assertion":[{"value":"11 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PMF received consultant fees and grant\/other support from Allena Pharmaceuticals, Alnylam, Amgen, AstraZeneca, Bayer, Gilead, Otsuka Pharmaceuticals, Rocchetta, Vifor Pharma, and royalties as an author for UpToDate. VDA received consultant fees from Allena Pharmaceuticals. GG received lecture fees and grant\/other support from Alfa Sigma, Alexion, Alnylam, Amgen, Astellas, AstraZeneca, Baxter, Fresenius Kabi, GSK, Lilly, Medtronic, Roche diagnostics, Vifor Pharma, and royalties as an author for UpToDate. All other authors report no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki.\u00a0The study obtained Ethical Committee approval (Prot. 0006896\/e, 26\/03\/2020 Comitato Etico Universit\u00e0 degli Studi della Campania \u201cLuigi Vanvitelli\u201d\u2014Azienda Ospedaliera Universitaria \u201cLuigi Vanvitelli\u201d- AORN \u201cOspedali dei Colli\u201d; Prot. 3229 11\/03\/2021 Comitato Etico Fondazione Policlinico Gemelli; Prot n. 38525 28\/06\/2021 Comitato Etico Universit\u00e0 degli Studi di Verona).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients included in the study provided informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}